Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Total Non-Current Liabilities (2016 - 2025)

Neuroone Medical Technologies' Total Non-Current Liabilities history spans 6 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 24.3% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, down 24.3%, while the annual FY2025 figure was $2.4 million, 1.6% up from the prior year.
  • Total Non-Current Liabilities reached $1.4 million in Q4 2025 per NMTC's latest filing, down from $2.4 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.4 million in Q3 2025 to a low of $973725.0 in Q1 2021.
  • Average Total Non-Current Liabilities over 3 years is $1.8 million, with a median of $1.8 million recorded in 2024.
  • The largest YoY upside for Total Non-Current Liabilities was 1.6% in 2025 against a maximum downside of 24.3% in 2025.
  • A 3-year view of Total Non-Current Liabilities shows it stood at $973725.0 in 2021, then soared by 85.71% to $1.8 million in 2024, then fell by 24.3% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Total Non-Current Liabilities are $1.4 million (Q4 2025), $2.4 million (Q3 2025), and $1.6 million (Q2 2025).